Produkty 2191318-99-5

CAS 2191318-99-5 występuje w naszej ofercie pod nazwami: (3R,4S)-1-(2-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one, 98%, Ezetimibe Impurity 50, Ezetimibe Impurity 71. Oferty producentów: Chemat Brand, Hubei YoungXin. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg.

(3R,4S)-1-(2-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one, 98%
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Ezetimibe Impurity 50
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Ezetimibe Impurity 71
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt

(3R,4S)-1-(2-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one (CAS 2191318-99-5) to związek chemiczny o wzorze sumarycznym C24H21F2NO3 i masie molowej 409.4 g/mol. Nazwa systematyczna IUPAC: (3R,4S)-1-(2-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one. InChIKey: VGJFIJYSSAPUPG-WTIAFYNJSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H21F2NO3
Masa molowa409.4 g/mol
Nazwa IUPAC(3R,4S)-1-(2-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
InChIKeyVGJFIJYSSAPUPG-WTIAFYNJSA-N
SMILESC1=CC=C(C(=C1)N2[C@@H]([C@H](C2=O)CC[C@@H](C3=CC=C(C=C3)F)O)C4=CC=C(C=C4)O)F

Dane obliczone przez PubChem (NCBI)

Synonimy: Ezetimibe Impurity 50, Ezetimibe Impurity 3
Izomery (ten sam wzór sumaryczny)
(3R,4R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(3S,4R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(3R,4S)-1-(3-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(E,2R)-2-[(S)-(4-fluoroanilino)-(4-hydroxyphenyl)methyl]-5-(4-fluorophenyl)pent-4-enoic acid C24H21F2NO3
(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(3R,4S)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-(2,3,5,6-tetradeuterio-4-fluorophenyl)azetidin-2-one C24H21F2NO3
(3S,4S)-1-(4-fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(3S,4R)-1-(4-fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(2R,3R,6S)-N,6-bis(4-fluorophenyl)-2-(4-hydroxyphenyl)oxane-3-carboxamide C24H21F2NO3
(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxy(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)azetidin-2-one C24H21F2NO3
(3R,4S)-1-(4-fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3
(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(2-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one C24H21F2NO3